Home > Name List By s > sodium

CAS No 34089-81-1 , sodium

  • Name: sodium
  • Synonyms: Ferrlecit; Sodium ferric gluconate complex; Sodium ferric gluconate complex (USAN); Sodium ferric gluconate;iron(3+); iron(3+) sodium salt;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate; D-Gluconic acid;sodium;
  • CAS Registry Number:
  • Flash Point: 375.1°C
  • Boiling Point: 673.6°Cat760mmHg
  • Density: g/cm3
  • Flash Point: 375.1°C
  • Molecular Weight: 273.982109
  • InchiKey: PKNUOQOQWGOWBO-ZBHRUSISSA-M
  • InChI: InChI=1S/C6H12O7.Fe.Na/c7-1-2(8)3(9)4(10)5(11)6(12)13;;/h2-5,7-11H,1H2,
    (H,12,13);;/q;+3;+1/p-1/t2-,3-,4+,5-;;/m1../s1
  • Molecular Formula: C6H11FeNaO7+3
  • Molecular Structure:CAS No:34089-81-1 sodium

Related products

Select to

34089-81-1 Sodium Ferric Gluconate

  • China Welpharm Co.,Ltd [Manufacturers]
  • Tel: +86-21-58690818 ,58690828
  • Fax: +86-21-58690838
  • Address: No. 2021 Tomson Bldg., 1 Keelung Rd., Pudong Shanghai, China Shanghai,ShanghaiChina
Contact Supplier

34089-81-1 Sodium ferric gluconate(injectable grade)

Contact Supplier

Select to

1/1
References of sodium
Title: Sodium Ferric Gluconate
CAS Registry Number: 34089-81-1
CAS Name: D-Gluconic acid iron(3+) sodium salt
Literature References: Bioavailable iron supplement containing a ferric hydroxide core stabilized and solubilized by simple carbohydrates. Prepn: W. Traube et al., Ber. 66B, 1545 (1933). Intestinal absorption of clinical formulations: L. Samochowiec, Clin. Ter. 56, 341 (1971).
 
Derivative Type: Sodium ferric gluconate complex
Trademarks: Ferlixit (Aventis); Ferrlecit (Watson); Ferrosprint (Pfizer); Sanifer (Esseti)
Literature References: Aqueous iron formulation administered as an injectable, stable, macromolecular iron saccharate complex. Gluconate bridges the iron centers. Mol formula is approximately: [NaFe2O3(C6H11O7)(C12H22O11)5]n. Apparent mol wt 289-440 kDa. Safety profile: G. Faich, J. Strobos, Am. J. Kidney Dis. 33, 464 (1999). Clinical evaluation in hemodialysis patients: A. R. Nissenson et al., ibid. 471; and comparison with iron dextran: B. Michael et al., Kidney Int. 61, 1830 (2002). Clinical pharmacokinetics: P. A. Seligman et al., Pharmacotherapy 24, 574 (2004). Clinical evaluation in renal transplant patients: R. S. Gillespie, J. M. Symons, Pediatr. Transplant. 9, 43 (2005). Review of therapeutic applications: S. Fishbane, J. Wagner, Am. J. Kidney Dis. 37, 879-883 (2001).
Properties: Deep red color indicative of ferric oxide linkages.
 
Therap-Cat: Hematinic.
Keywords: Hematinic.